These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21945270)
41. Poly(lactic acid) (PLA) based nanocomposites--a novel way of drug-releasing. Chen C; Lv G; Pan C; Song M; Wu C; Guo D; Wang X; Chen B; Gu Z Biomed Mater; 2007 Dec; 2(4):L1-4. PubMed ID: 18458473 [TBL] [Abstract][Full Text] [Related]
42. Amphiphilic polylactic acid-hyperbranched polyglycerol nanoparticles as a controlled release system for poorly water-soluble drugs: physicochemical characterization. Gao X; Zhang X; Zhang X; Wang Y; Sun L; Li C J Pharm Pharmacol; 2011 Jun; 63(6):757-64. PubMed ID: 21585372 [TBL] [Abstract][Full Text] [Related]
43. Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres. Zhao H; Wu F; Cai Y; Chen Y; Wei L; Liu Z; Yuan W Int J Pharm; 2013 Jun; 450(1-2):235-40. PubMed ID: 23624084 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-d,l-lactic acid. Kumanohoso T; Natsugoe S; Shimada M; Aikou T Cancer Chemother Pharmacol; 1997; 40(2):112-6. PubMed ID: 9182831 [TBL] [Abstract][Full Text] [Related]
45. Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics. Coowanitwong I; Arya V; Patel G; Kim WS; Craciun V; Rocca JR; Singh R; Hochhaus G J Pharm Pharmacol; 2007 Nov; 59(11):1473-84. PubMed ID: 17976257 [TBL] [Abstract][Full Text] [Related]
46. Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained Diclofenac prodrug to treat actinic keratosis. Piccirillo G; Bochicchio B; Pepe A; Schenke-Layland K; Hinderer S Acta Biomater; 2017 Apr; 52():187-196. PubMed ID: 27816622 [TBL] [Abstract][Full Text] [Related]
47. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. He G; Ma LL; Pan J; Venkatraman S Int J Pharm; 2007 Apr; 334(1-2):48-55. PubMed ID: 17116377 [TBL] [Abstract][Full Text] [Related]
48. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654 [TBL] [Abstract][Full Text] [Related]
49. Modified PLA nano in situ gel: a potential ophthalmic drug delivery system. Nagarwal RC; Kumar R; Dhanawat M; Pandit JK Colloids Surf B Biointerfaces; 2011 Aug; 86(1):28-34. PubMed ID: 21497491 [TBL] [Abstract][Full Text] [Related]
50. Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions. Morgen M; Lu GW; Du D; Stehle R; Lembke F; Cervantes J; Ciotti S; Haskell R; Smithey D; Haley K; Fan C Int J Pharm; 2011 Sep; 416(1):314-22. PubMed ID: 21722722 [TBL] [Abstract][Full Text] [Related]
51. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles. Zhou MX; Chang TM J Microencapsul; 1988; 5(1):27-36. PubMed ID: 3199299 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles. Naha PC; Kanchan V; Panda AK J Biomater Appl; 2009 Nov; 24(4):309-25. PubMed ID: 18987018 [TBL] [Abstract][Full Text] [Related]
53. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
54. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation. Jeevitha D; Amarnath K Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782 [TBL] [Abstract][Full Text] [Related]
56. Poly(lactic acid)/N-maleoylchitosan core-shell capsules: preparation and drug release properties. Zhu A; Li F; Ji L Colloids Surf B Biointerfaces; 2012 Mar; 91():162-7. PubMed ID: 22100385 [TBL] [Abstract][Full Text] [Related]
57. Improvement in autologous human fat transplant survival with SVF plus VEGF-PLA nano-sustained release microspheres. Li L; Pan S; Ni B; Lin Y Cell Biol Int; 2014 Aug; 38(8):962-70. PubMed ID: 24740717 [TBL] [Abstract][Full Text] [Related]
58. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol. Xinteng Z; Weisan P; Ruhua Z; Feng Z Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951 [TBL] [Abstract][Full Text] [Related]
59. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. Lu Y; Yu Y; Tang X J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936 [TBL] [Abstract][Full Text] [Related]
60. [PLA-O-CMC nanoparticles: HGF loading and delivery behaviors in vitro]. Li Z; Chen Z; Chang R Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):314-7. PubMed ID: 21604493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]